Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: February 16, 2006
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)